The structural impact of cancer-associated missense mutations in oncogenes and tumor suppressors

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Stehr, Henning ^a   Jang, Seon Hi J ^a,b   Duarte, José M ^c   Wierling, Christoph ^a   Lehrach, Hans ^a   Lappe, Michael ^a   Lange, Bodo M H ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; B RAF KINASE; GUANOSINE TRIPHOSPHATE; K RAS PROTEIN; PROTEIN KINASE B; PROTEIN KINASE LKB1; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SCATTER FACTOR RECEPTOR; SMAD4 PROTEIN; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN; WT1 PROTEIN; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BINDING SITE; BREAST CANCER; GENE ACTIVATION; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; KIDNEY CANCER; LUNG CANCER; MISSENSE MUTATION; ONCOGENE; ONCOGENE N RAS; PANCREAS CANCER; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; THYROID CANCER; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC DATABASE; GENETICS; MOLECULAR GENETICS; NEOPLASM; PATHOLOGY; PROTEIN STABILITY;

DATABASES, GENETIC; HUMANS; MODELS, GENETIC; MODELS, MOLECULAR; MOLECULAR SEQUENCE ANNOTATION; MOLECULAR STRUCTURE; MUTATION, MISSENSE; NEOPLASMS; ONCOGENE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STABILITY; TUMOR SUPPRESSOR PROTEINS;

EID: 79955907500     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-54     Document Type: Article

References (44)

1. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113. 10.1126/science.1145720, 17932254.
2. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (New York, NY) 2008, 321:1801-1806.
3. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158. 10.1038/nature05610, 2712719, 17344846.
4. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274. 10.1126/science.1133427, 16959974.
5. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010, 463:191-196. 10.1038/nature08658, 20016485.
6. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010, 463:184-190. 10.1038/nature08629, 2880489, 20016488.
7. CancerGenome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. 10.1038/nature07385, 2671642, 18772890, CancerGenome Atlas Research Network.
8. Hurst JM, McMillan LE, Porter CT, Allen J, Fakorede A, Martin AC. The SAAPdb web resource: a large-scale structural analysis of mutant proteins. Hum Mutat 2009, 30:616-624. 10.1002/humu.20898, 19191322.
9. Talavera D, Taylor MS, Thornton JM. The (non)malignancy of cancerous amino acidic substitutions. Proteins 2010, 78:518-529.
10. Chittenden TW, Howe EA, Culhane AC, Sultana R, Taylor JM, Holmes C, Quackenbush J. Functional classification analysis of somatically mutated genes in human breast and colorectal cancers. Genomics 2008, 91:508-511. 10.1016/j.ygeno.2008.03.002, 2492759, 18434084.
11. Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 2006, 7:61-80. 10.1146/annurev.genom.7.080505.115630, 16824020.
12. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic acids research 2003, 31:3812-3814. 10.1093/nar/gkg509, 168916, 12824425.
13. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic acids research 2002, 30:3894-3900. 10.1093/nar/gkf493, 137415, 12202775.
14. Wang Z, Moult J. SNPs, protein structure, and disease. Human Mutation 2001, 17:263-270. 10.1002/humu.22, 11295823.
15. Karchin R. Next generation tools for the annotation of human SNPs. Brief Bioinform 2009, 10:35-52. 2638621, 19181721.
16. Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, Clements J, Menzies A, Teague JW, Futreal PA, Stratton MR. The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet 2008, Chapter 10. Unit 10 11.
17. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, Dicuccio M, Edgar R, Federhen S, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2008, 36:D13-21. 2238880, 18045790.
18. Berman H, Henrick K, Nakamura H. Announcing the worldwide Protein Data Bank. Nat Struct Biol 2003, 10:980. 10.1038/nsb1203-980, 14634627.
19. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25:3389-3402. 10.1093/nar/25.17.3389, 146917, 9254694.
20. Hubbard SJ, Thornton JM. NACCESS, Computer Program, Department of Biochemistry and Molecular Biology, University College London. 1993,
21. Guerois R, Nielsen JE, Serrano L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 2002, 320:369-387. 10.1016/S0022-2836(02)00442-4, 12079393.
22. Dill KA. Dominant forces in protein folding. Biochemistry 1990, 29:7133-7155. 10.1021/bi00483a001, 2207096.
23. TheUniProt Consortium The Universal Protein Resource (UniProt) in 2010. Nucl Acids Res 2010, 38:D142-148. 2808944, 19843607, TheUniProt Consortium.
24. Porter CT, Bartlett GJ, Thornton JM. The Catalytic Site Atlas: a resource of catalytic sites and residues identified in enzymes using structural data. Nucleic Acids Res 2004, 32:D129-133. 10.1093/nar/gkh028, 308762, 14681376.
25. Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E, Zhang B. PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 2004, 4:1551-1561. 10.1002/pmic.200300772, 15174125.
26. Xu Y, Xu D, Gabow HN. Protein domain decomposition using a graph-theoretic approach. Bioinformatics 2000, 16:1091-1104. 10.1093/bioinformatics/16.12.1091, 11159328.
27. Fisher RA. The Use of Multiple Measurements in Taxonomic Problems. Annals of Eugenics 1936, 7:179-188.
28. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993, 9:138-141. 10.1016/0168-9525(93)90209-Z, 8516849.
29. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29:308-311. 10.1093/nar/29.1.308, 29783, 11125122.
30. Potapov V, Cohen M, Schreiber G. Assessing computational methods for predicting protein stability upon mutation: good on average but not in the details. Protein Eng Des Sel 2009, 22:553-560. 10.1093/protein/gzp030, 19561092.
31. Lee DJ, Schonleben F, Banuchi VE, Qiu W, Close LG, Assaad AM, Su GH. Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis. Cancer Biol Ther 2010, 10.
32. Gong S, Blundell TL. Structural and functional restraints on the occurrence of single amino acid variations in human proteins. PLoS One 2010, 5:e9186. 10.1371/journal.pone.0009186, 2820541, 20169194.
33. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954. 10.1038/nature00766, 12068308.
34. Shu HK, Pelley RJ, Kung HJ. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential. Proc Natl Acad Sci USA 1990, 87:9103-9107. 10.1073/pnas.87.23.9103, 55112, 1979168.
35. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B, VandeWoude GF. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 1997, 94:11445-11450. 10.1073/pnas.94.21.11445, 23495, 9326629.
36. Torkamani A, Schork NJ. Prediction of cancer driver mutations in protein kinases. Cancer Res 2008, 68:1675-1682. 10.1158/0008-5472.CAN-07-5283, 18339846.
37. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003, 3:459-465. 10.1038/nrc1097, 12778136.
38. Pai EF, Kabsch W, Krengel U, Holmes KC, John J, Wittinghofer A. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature 1989, 341:209-214. 10.1038/341209a0, 2476675.
39. Yue P, Forrest WF, Kaminker JS, Lohr S, Zhang Z, Cavet G. Inferring the functional effects of mutation through clusters of mutations in homologous proteins. Hum Mutat 2010, 31:264-271. 10.1002/humu.21194, 20052764.
40. Ye J, Pavlicek A, Lunney EA, Rejto PA, Teng CH. Statistical method on nonrandom clustering with application to somatic mutations in cancer. BMC Bioinformatics 2010, 11:11. 10.1186/1471-2105-11-11, 2822753, 20053295.
41. Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW, Vogelstein B, Karchin R. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Research 2009, 69:6660-6667. 10.1158/0008-5472.CAN-09-1133, 2763410, 19654296.
42. Kaminker JS, Zhang Y, Waugh A, Haverty PM, Peters B, Sebisanovic D, Stinson J, Forrest WF, Bazan JF, Seshagiri S, Zhang Z. Distinguishing cancer-associated missense mutations from common polymorphisms. Cancer Res 2007, 67:465-473. 10.1158/0008-5472.CAN-06-1736, 17234753.
43. Huang CH, Mandelker D, Gabelli SB, Amzel LM. Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha. Cell Cycle 2008, 7:1151-1156. 10.4161/cc.7.9.5817, 18418043.
44. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA 2010, 107:18545-18550. 10.1073/pnas.1010978107, 2972991, 20876136.